SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (10891)11/8/1997 1:18:00 PM
From: tonyt  Read Replies (1) | Respond to of 32384
 
> Still its a good sign that such a high number of subjects continue to use the drug.

Not only 'use' the drug, they "can't pry the drug out of their hands":

"Over 75% percent of the people in the two studies have elected to continue using (Amylins's) pramlintide. "I can't pry the drug out of their hands," says Davida Kruger, a nurse practitioner at Detroit's Henry Ford Health Systems. Besides taking less insulin, Evelyn Hawkins says she has lost weight and now can walk three miles several times a week."



To: Andrew H who wrote (10891)11/8/1997 4:28:00 PM
From: Hippieslayer  Read Replies (2) | Respond to of 32384
 
Andy,

OFF topic:

Since the idiots at ABC decided to show the USC/Stanford game, I have to listening to the UM/PSU game on the radio.

17-0 favor of UM in 2nd half. If Mich can keep the PSU's offense/Ennis from scoring, the number #1 spot is theirs. No if, ands, or buts.
Game is still young. PSU can come back.

BTW, what happened to the LGND news?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News